113 related articles for article (PubMed ID: 11191363)
1. The NADPH oxidase inhibitors iodonium diphenyl and cadmium sulphate inhibit hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries.
Jones RD; Thompson JS; Morice AH
Physiol Res; 2000; 49(5):587-96. PubMed ID: 11191363
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries by diphenyleneiodonium (DPI).
Thompson JS; Jones RD; Rogers TK; Hancock J; Morice AH
Pulm Pharmacol Ther; 1998 Feb; 11(1):71-5. PubMed ID: 9802966
[TBL] [Abstract][Full Text] [Related]
3. The ETA antagonist CI-1020 inhibits hypoxic pulmonary vasoconstriction in small isolated rat pulmonary arteries.
Jones RD; Morice AH
Pulm Pharmacol Ther; 1998; 11(2-3):177-81. PubMed ID: 9918752
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction.
Marshall C; Mamary AJ; Verhoeven AJ; Marshall BE
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):633-44. PubMed ID: 8918370
[TBL] [Abstract][Full Text] [Related]
5. The effect of hydrogen peroxide on hypoxia, prostaglandin F2 alpha and potassium chloride induced contractions in isolated rat pulmonary arteries.
Jones RD; Thompson JS; Morice AH
Pulm Pharmacol Ther; 1997; 10(1):37-42. PubMed ID: 9344831
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries is not inhibited by antagonists of H2 S-synthesizing pathways.
Prieto-Lloret J; Shaifta Y; Ward JP; Aaronson PI
J Physiol; 2015 Jan; 593(2):385-401. PubMed ID: 25630260
[TBL] [Abstract][Full Text] [Related]
7. Effect of levcromakalim on hypoxia-, KCl- and prostaglandin F2 alpha-induced contractions in isolated rat pulmonary artery.
Zhang F; Morice AH
J Pharmacol Exp Ther; 1994 Oct; 271(1):326-33. PubMed ID: 7965732
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic pulmonary vasoconstriction in isolated mouse pulmonary arterial vessels.
Strielkov I; Krause NC; Sommer N; Schermuly RT; Ghofrani HA; Grimminger F; Gudermann T; Dietrich A; Weissmann N
Exp Physiol; 2018 Sep; 103(9):1185-1191. PubMed ID: 29917290
[TBL] [Abstract][Full Text] [Related]
9. Role of pentose phosphate pathway-derived NADPH in hypoxic pulmonary vasoconstriction.
Gupte SA; Okada T; McMurtry IF; Oka M
Pulm Pharmacol Ther; 2006; 19(4):303-9. PubMed ID: 16203165
[TBL] [Abstract][Full Text] [Related]
10. Impact of mitochondria and NADPH oxidases on acute and sustained hypoxic pulmonary vasoconstriction.
Weissmann N; Zeller S; Schäfer RU; Turowski C; Ay M; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Grimminger F
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):505-13. PubMed ID: 16357364
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
12. Acute hypoxic vasoconstriction in isolated rat small and large pulmonary arteries.
Zhang F; Woodmansey PA; Morice AH
Physiol Res; 1995; 44(1):7-18. PubMed ID: 8789294
[TBL] [Abstract][Full Text] [Related]
13. An almitrine analog acts as hypoxia in isolated rat lungs.
Robineau P; Dhainaut A; Canet E
Respir Physiol; 1996 Sep; 105(3):225-33. PubMed ID: 8931182
[TBL] [Abstract][Full Text] [Related]
14. Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungs.
Grimminger F; Weissmann N; Spriestersbach R; Becker E; Rosseau S; Seeger W
Am J Physiol; 1995 May; 268(5 Pt 1):L747-52. PubMed ID: 7762677
[TBL] [Abstract][Full Text] [Related]
15. Prominent role of intracellular Ca2+ release in hypoxic vasoconstriction of canine pulmonary artery.
Jabr RI; Toland H; Gelband CH; Wang XX; Hume JR
Br J Pharmacol; 1997 Sep; 122(1):21-30. PubMed ID: 9298524
[TBL] [Abstract][Full Text] [Related]
16. Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction.
Frazziano G; Moreno L; Moral-Sanz J; Menendez C; Escolano L; Gonzalez C; Villamor E; Alvarez-Sala JL; Cogolludo AL; Perez-Vizcaino F
J Cell Physiol; 2011 Oct; 226(10):2633-40. PubMed ID: 21792922
[TBL] [Abstract][Full Text] [Related]
17. Gap junctions support the sustained phase of hypoxic pulmonary vasoconstriction by facilitating calcium sensitization.
Kizub IV; Strielkov IV; Shaifta Y; Becker S; Prieto-Lloret J; Snetkov VA; Soloviev AI; Aaronson PI; Ward JP
Cardiovasc Res; 2013 Aug; 99(3):404-11. PubMed ID: 23708740
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery smooth muscle cell [Ca2+]i and contraction: responses to diphenyleneiodonium and hypoxia.
Zhang F; Carson RC; Zhang H; Gibson G; Thomas HM
Am J Physiol; 1997 Sep; 273(3 Pt 1):L603-11. PubMed ID: 9316495
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs.
Weissmann N; Voswinckel R; Tadic A; Hardebusch T; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):222-7. PubMed ID: 10919989
[TBL] [Abstract][Full Text] [Related]
20. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing.
Waypa GB; Chandel NS; Schumacker PT
Circ Res; 2001 Jun; 88(12):1259-66. PubMed ID: 11420302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
